ArticleThe Journal of reproduction and development2026
Malonic acid promotes glycolytic activity in cumulus cells and improves the quality of bovine oocytes matured in vitro.
Article in The Journal of reproduction and development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malonic acid (MA) is a dicarboxylic acid that inhibits the mitochondrial electron transport chain. Cumulus cells surrounding human oocytes that achieve conception after in vitro fertilization (IVF) contain higher levels of MA than those that do not. Although MA has no effect on embryo developmental culture, the effects of MA on cumulus cells and oocyte quality remain unclear. In this study, the addition of 10 μM MA to the in vitro maturation (IVM) medium cultured cumulus cell-oocyte complexes improved embryo production efficiency, meeting multiple conception-related criteria after IVF (P < 0.05). MA did not affect the nuclear maturation rate of oocytes after IVM; however, it increased lipid content and normal alignment ratio of cortical granules (P < 0.05), both of which are indicators of cytoplasmic maturation of oocytes. MA also increased the adenosine triphosphate (ATP) content in oocytes only when they were present with cumulus cells (P < 0.05). MA decreased mitochondrial membrane potential activity in cumulus cells but increased the ATP content and enhanced glycolytic activity (P < 0.05). The use of a glycolysis inhibitor resulted in a decrease in the ATP content of both cumulus cells and oocytes and reduced the amount of lipids in oocytes (P < 0.05). These results indicate that MA shifts ATP production in cumulus cells from the mitochondrial to the glycolytic pathway, resulting in improved ATP synthesis. Furthermore, an increased ATP supply from cumulus cells to oocytes promotes oocyte cytoplasmic maturation, leading to improved quality of IVF embryos.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.